Co-existence of hypertensive urgency and hemolysis elevated liver enzymes and low platelets syndrome in a parturient with myasthenia gravis: a therapeutic challenge
DOI:
https://doi.org/10.18203/2320-1770.ijrcog20220922Keywords:
HELLP syndrome, Myasthenia gravis, Pregnancy, Preeclampsia, Multidisciplinary approachAbstract
Hemolysis elevated liver enzymes and low platelets (HELLP syndrome) is an obstetric emergency developed in the settings of hypertensive disorder of pregnancy and it is associated with a heightened risk of adverse fetomaternal outcomes. Obstetric and anaesthetic management is indeed challenging in HELLP syndrome. The presence of myasthenia gravis further complicates the managements issues in these women. Here, in this report, we describe a 35 years G2P1L1 known case of myasthenia gravis, who presented in emergency with uncontrolled hypertension, imminent eclampsia and HELLP syndrome at 29+1 weeks of gestation. Antihypertensive medication included hydralazine, alpha methyldopa, infusions of labetolol and nitroglycerine. She underwent successful vaginal delivery using fentanyl as labour analgesia. Prompt decision making using multidisciplinary team appeared vital in controlling the hypertension adequately and quickly without aggravating myasthenic crisis.
References
Tesfa E, Nibret E, Gizaw ST, Zenebe Y, Mekonnen Z, Assefa S et al. Prevalence and determinants of hypertensive disorders of pregnancy in Ethiopia: A systematic review and meta-analysis. PLoS One. 2020;15(9):e0239048.
Alese MO, Moodley J, Naicker T. Preeclampsia and HELLP syndrome, the role of the liver. J Matern Fetal Neonatal Med. 2021;34(1):117-23.
Wen JC, Liu TC, Chen YH, Chen SF, Lin HC, Tsai WC. No increased risk of adverse pregnancy outcomes for women with myasthenia gravis: a nationwide population-based study. Eur J Neurol. 2009;16:889-94.
Qi QW, Wang D, Liu JT, Bian XM. Management of pregnancy with myasthenia gravis: 7 cases report. Zhonghua Fu Chan Ke ZaZhi. 2012;47:241-4.
Roche P, Bouhour F. Myasthenia gravis and pregnancy. Rev Neurol (Paris). 2021;177(3):215-9.
Lisonkova S, Razaz N, Sabr Y, Muraca GM, Boutin A, Mayer C et al. Maternal risk factors and adverse birth outcomes associated with HELLP syndrome: a population-based study. BJOG. 2020;127(10):1189-98.
Lake AJ, Al Khabbaz A, Keeney R. Severe Preeclampsia in the Setting of Myasthenia Gravis. Case Rep Obstetr Gynecol. 2017;2017:1-5.
Nicholls-Dempsey L, Czuzoj-Shulman N, Abenhaim HA. Maternal and neonatal outcomes among pregnant women with myasthenia gravis. J Perinat Med. 2020;48(8):793-8.
Hamel J, Ciafaloni E. An Update: Myasthenia Gravis and Pregnancy. Neurol Clin. 2018;36(2):355-65.
del-Rio-Vellosillo M, Garcia-Medina JJ. Anesthetic considerations in HELLP syndrome. Acta Anaesthesiol Scand. 2016;60(2):144-57.
Blichfeldt-Lauridsen L, Hansen BD. Anesthesia and myasthenia gravis. Acta Anaesthesiol Scand. 2012;56(1):17-22.
Varner M. Myasthenia gravis and pregnancy. Clin Obstet Gynecol. 2013;56(2):372-81.
Chaudhry SA, Vignarajah B, Koren G. Myasthenia gravis during pregnancy. Can Fam Physician. 2012;58:1346-9.
Djelmis J, Sostarko M, Mayer D, Ivanisevic M. Myasthenia gravis in pregnancy: report on 69 cases. Eur J Obstet Gynecol Reprod Biol. 2002;104(1):21-5.
Cohen BA, London RS, Goldstein PJ. Myasthenia gravis and preeclampsia. Obstet Gynecol 1976;48:35S-7.
